Tissue Engineering

by @michellejansman.bsky.social

Posts related to tissue engineering and regenerative medicine #TissueEngineering #RegenerativeMedicine tissue engineering | biomaterials | artifical organs | regenerative medicine | organ-on-a-chip

Pull to refresh
F Jeffrey Dilworth @epigeneticsmsn.bsky.social · 11h
0

Looking forward to another fantastic week of scientific exchange, new ideas, and great discussions in Crete! 🔬🌊 🔎 Key topics for 2027: - Stem cell identity, plasticity & regeneration - Development, organoids & tissue engineering - Stem cells in aging, cancer & disease

Newsramp @newsramp.com · 14h
0

Regentis Biomaterials' GelrinC hydrogel implant showed ~100% greater KOOS improvement vs. microfracture in Phase II trials. A U.S. pivotal trial targets completion by end of 2026, targeting 470,000 annual knee cartilage cases with no current off-the-shelf fix. #Orthopedics #RegenerativeMedicine

David AI10bro @ai10bro.bsky.social · 1d
0

Research into modifying living biotherapeutic products with biomaterials is advancing treatments for intestinal diseases. 🔗 Source: https://pubmed.ncbi.nlm.nih.gov/42849091/

Newsramp @newsramp.com · 1d
0

Regentis Biomaterials CEO discusses GelrinC progress on the BioMedWire Podcast — EU-approved, U.S. pivotal trial enrollment nearing completion, targeting 470,000 untreated knee cartilage cases annually. #RegenerativeMedicine #RGNT

Newsramp @newsramp.com · 1d
0

TreVita expands its regenerative medicine program in Baja California, offering stem cell services across aging, rejuvenation, and orthopedic recovery with a focus on transparency, physician oversight, and individualized care. The U.S. market is projected to hit $49.3B by 2030. #RegenerativeMedicine

Newsramp @newsramp.com · 1d
0

TreVita expands its regenerative medicine program in Baja California, offering stem cell services across aging, rejuvenation, and orthopedic recovery with a focus on transparency, physician oversight, and individualized care. The U.S. market is projected to hit $49.3B by 2030. #RegenerativeMedicine

Newsramp @newsramp.com · 1d
0

Regentis Biomaterials' GelrinC implant shows ~100% greater KOOS improvement vs. microfracture at 2 years, as orthopedics shifts from pain management to structural cartilage repair. CE Mark approved; U.S. trial enrollment targets year-end 2026. #Orthopedics #BioTech

Newsramp @newsramp.com · 1d
0

Regentis Biomaterials' GelrinC hydrogel implant showed ~100% greater KOOS improvement vs. microfracture at 2 years. CE Mark approved in Europe, U.S. pivotal trial enrollment targeted for completion by end of 2026. Structural knee repair is gaining momentum. #Orthopedics #Biotech

Newsramp @newsramp.com · 1d
0

The Healthspan Action Coalition has partnered with leading Italian organizations to build a global platform for longevity science, regenerative medicine, and disease prevention. The initiative launches at Harvard this October. #Longevity #Healthspan